Gene · 1066
Papers3,256
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,256
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of adverse perinatal outcomes on postpartum maternal mental health in low-income and middle-income countries: a protocol for systematic review. | BMJ Open | 2023 | 38101849 | PubTator, text mining | PubMed |
| Dysregulated cholesterol regulatory genes in hepatocellular carcinoma. | Eur J Med Res | 2023 | 38071335 | PubTator, text mining | PubMed |
| Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics. | Front Pharmacol | 2023 | 38044943 | PubTator, text mining | PubMed |
| A Shared Perspective on in Vitro and in Vivo Models to Assay Intestinal Transepithelial Transport of Food Compounds. | J Agric Food Chem | 2023 | 38035628 | PubTator, text mining | PubMed |
| Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants. | Front Pharmacol | 2023 | 38034995 | PubTator, text mining | PubMed |
| Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome. | Front Endocrinol (Lausanne) | 2023 | 38034016 | PubTator, text mining | PubMed |
| The cross-talk between macrophages and tumor cells as a target for cancer treatment. | Front Oncol | 2023 | 38033495 | PubTator, text mining | PubMed |
| Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking. | Curr Pharm Des | 2023 | 38018195 | PubTator, text mining | PubMed |
| The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors. | Viruses | 2023 | 38005911 | PubTator, text mining | PubMed |
| Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients. | Pharmaceutics | 2023 | 38004528 | PubTator, text mining | PubMed |
| Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride. | J Pers Med | 2023 | 38003881 | PubTator, text mining | PubMed |
| A Comprehensive Assessment of Tear-Film-Oriented Diagnosis (TFOD) in a Dacryoadenectomy Dry Eye Model. | Int J Mol Sci | 2023 | 38003700 | PubTator, text mining | PubMed |
| The Impact of Data on Structure-Based Binding Affinity Predictions Using Deep Neural Networks. | Int J Mol Sci | 2023 | 38003312 | PubTator, text mining | PubMed |
| Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk. | Genes (Basel) | 2023 | 38003001 | PubTator, text mining | PubMed |
| Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1. | J Biomed Res | 2023 | 37990879 | PubTator, text mining | PubMed |
| Changes in alcohol consumption according to the duration of unemployment: prospective findings from the French CONSTANCES cohort. | BMJ Open | 2023 | 37984957 | PubTator, text mining | PubMed |
| Mild Cognitive Impairment among Elderly Persons Residing in an Urban Resettlement Colony in Delhi. | Indian J Community Med | 2023 | 37970150 | PubTator, text mining | PubMed |
| Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. | EMBO J | 2023 | 37962490 | PubTator, text mining | PubMed |
In silico analysis of selected nutrition rich fruit of Bunch berry (Lantana camara) constituents as human acetylcholinesterase (hAchE), carbonic anhydrase II (hCA-II) and carboxylesterase 1 (hCES-1) inhibitory agents. | Saudi J Biol Sci | 2023 | 37961045 | PubTator, text mining | PubMed |
| Polymer-prodrug conjugates as candidates for degradable, long-acting implants, releasing the water-soluble nucleoside reverse-transcriptase inhibitor emtricitabine. | J Mater Chem B | 2023 | 37955203 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1066/papers?page=14